Revelation Pharma (Osceola Capital) Acquires Five Compounding Pharmacies
January 27, 2022
Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).
- Buyers
- Revelation Pharma, Osceola Capital
- Targets
- Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, Convex Pharmacy
- Platforms
- Revelation Pharma
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Osceola Capital-Backed Revelation Pharma Acquires Everwell Specialty Pharmacy
March 23, 2021
Healthcare Services
Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.
-
Revelation Pharma (Osceola Capital) Acquires Eagle Pharmacy and Lee Silsby Compounding Pharmacy
July 13, 2023
Healthcare Services
Osceola Capital’s platform company Revelation Pharma acquired Eagle Pharmacy (Hoover, Alabama) and Lee Silsby Compounding Pharmacy (Beachwood, Ohio), marking the seventeenth and eighteenth add-ons to the Revelation platform. The acquisitions expand Revelation’s 503A/503B compounding capabilities and geographic reach, adding scale, diversification, and capacity to serve patients, prescribers, and healthcare facilities nationwide.
-
Revelation Pharma (Osceola Capital) Acquires Harrow Health's Non‑Ophthalmic Compounding Business
October 12, 2022
Healthcare Services
Osceola Capital-backed Revelation Pharma has acquired the non-ophthalmic compounding business of NASDAQ-listed Harrow Health as the twelfth add-on to the Revelation platform. The deal lets Revelation expand its national footprint of 503A and 503B compounding pharmacies while Harrow focuses solely on ophthalmic medications.
-
Revelation Pharma Acquires Wedgewood Pharmacy's Human-Health Book of Business
June 16, 2022
Healthcare Services
Osceola Capital's Revelation Pharma platform acquired the human-health book of business from Wedgewood Pharmacy, marking the eighth add-on for the Revelation platform. The deal allows Wedgewood to focus exclusively on veterinary compounding while expanding Revelation's national network of 503A/503B compounding pharmacies; terms were not disclosed.
-
Revelation Pharma Acquires Taylors Pharmacy and Key Compounding Pharmacy
July 9, 2024
Healthcare Services
Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Taylors Pharmacy (Florida) and Key Compounding Pharmacy (Federal Way, Washington). The acquisitions expand Revelation's coast-to-coast footprint and bring both pharmacies into its compounding network as Revelation assumes full operations; the sellers are the founders/owners Allen Deaver and HeeJoo Park.
-
Revelation Pharma Acquires Acacia Apothecary & Wellness
October 9, 2025
Healthcare Services
Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Acacia Apothecary & Wellness, a Tucson-based compounding pharmacy. The deal expands Revelation's footprint and expertise in hormone therapy, women's health, and personalized medicine; Acacia founder Justin Brock, PharmD, will join Revelation as an Operational Consultant.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.